back to US directory
us clinical guidance

PTSD assessment and evidence-based treatment

VA/DoD-aligned diagnostic assessment, trauma-focused psychotherapy, selected pharmacotherapy and comorbidity-aware follow-up.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with possible acute stress disorder or posttraumatic stress disorder after exposure to a qualifying traumatic event. The 2023 VA/DoD guideline addresses assessment, diagnosis, prevention and treatment.
sources for this section:VA/DoD PTSD 2023

The Bottom Line

  • Confirm trauma exposure, symptom clusters, duration, distress and impairment with a clinical assessment; a PTSD checklist supports measurement but does not replace diagnosis.
  • Offer an individual, manualized trauma-focused psychotherapy鈥攕uch as prolonged exposure, cognitive processing therapy or eye movement desensitization and reprocessing鈥攂efore medication when feasible and preferred.
  • When pharmacotherapy is chosen, the VA/DoD guideline supports selected antidepressants including sertraline, paroxetine or venlafaxine; use current labeling, comorbidity and patient preference to select safely.
  • Reassess PTSD symptoms, function, quality of life, safety, adherence and comorbidity after an adequate treatment interval and address barriers before declaring failure.
sources for this section:VA/DoD PTSD 2023

Practical clinical workflow

1
Ask permission to discuss trauma, establish immediate safety and characterize intrusion, avoidance, negative mood or beliefs, arousal, dissociation, sleep, pain, substance use and functional impact.
2
Assess suicide and violence risk, depression, bipolarity, psychosis, traumatic brain injury, chronic pain, sleep disorders and substance-use disorder and coordinate rather than excluding patients from PTSD care.
3
Present effective psychotherapy and medication options without requiring detailed trauma disclosure in the initial visit, then connect the patient to a trained clinician and remove practical access barriers.
4
Use a consistent validated symptom measure during treatment, review adverse effects and progress and develop a maintenance and re-entry plan after meaningful improvement.
sources for this section:VA/DoD PTSD 2023

Safety boundaries and escalation

  • Current suicidal intent, violent risk, severe dissociation with unsafe behavior, psychosis, inability to care for self or dangerous intoxication or withdrawal needs urgent stabilization.
  • VA/DoD recommends against benzodiazepines and against cannabis or cannabis-derived products as PTSD treatment because benefit is not established and harms are important.
  • Do not force trauma narration, begin exposure work without consent and preparation or use untrained delivery of a manualized therapy; pacing and therapeutic alliance affect safety and completion.
  • Address firearm access, sleep, substance use, interpersonal violence and medical comorbidity explicitly; improvement in one symptom cluster does not establish whole-person safety.
sources for this section:VA/DoD PTSD 2023VA/DoD suicide risk 2024

Localization

VA/DoD recommendations apply across veteran, military and broader clinical contexts but access differs among VA, TRICARE, Medicaid and commercial systems. Secure video delivery can expand access when the chosen therapy is validated for it.
sources for this section:VA/DoD PTSD 2023

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. U.S. Department of Veterans Affairs and U.S. Department of Defense Evidence-Based Practice Work GroupVA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress DisorderVersion 4.0 (2023) 路 published 2023-06-01 路 accessed 2026-08-20
    view source
  2. U.S. Department of Veterans Affairs and U.S. Department of Defense Evidence-Based Practice Work GroupVA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide2024 guideline; official guideline page checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.